Skip to content

Good medium-term outcomes seen in antiretroviral-treated patients in Cambodia

Avoid d4T say investigators after finding high incidence of lactic acidosis in Botswana

Two and a half years extra ART if treatment starts at 500 CD4s, not 350

EACS: Nevirapine studies highlight new first-line uses

EACS: Kaletra monotherapy may need excellent adherence to work

EACS: CD4 cells: the lower you start, the lower you finish

EACS: Hospital admissions and appointments predict subsequent HIV diagnosis and death

Boosted saquinavir as good as Kaletra, Gemini study shows

Undetectable viral load is goal for all, together with earlier treatment, say new European treatment guidelines